REQUEST A DEMO
Total
USD $0.00
Search more companies

Phoenix Pharma Polska Sp. z o.o. (Poland)

Main Activities: Other Miscellaneous Nondurable Goods Merchant Wholesalers
Secondary Activities: General Line Grocery Merchant Wholesalers | All Other Specialty Food Stores | Pharmacies and Drug Stores | Cosmetics, Beauty Supplies, and Perfume Stores | Department Stores | Electronic Shopping and Mail-Order Houses | Warehousing and Storage | All Other Support Services
Full name: Phoenix Pharma Polska Sp. z o.o. Profile Updated: March 28, 2025
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Polish Download a sample report

Phoenix Pharma Polska Sp. z o.o. is an enterprise based in Poland. Its main office is in Konotopa. The enterprise currently operates in the Other Miscellaneous Nondurable Goods Merchant Wholesalers sector. The enterprise was incorporated on August 10, 2001. 60 (2022) employees currently work for Phoenix Pharma Polska Sp. z o.o.. From the latest financial highlights, Phoenix Pharma Polska Sp. z o.o. reported a net sales revenue increase of 67.11% in 2025. During that time, Phoenix Pharma Polska Sp. z o.o.’s total assets grew by 29.12%. The enterprise’s net profit margin decreased by 0.39% in 2025.

Headquarters
Ul. Rajdowa 9
Konotopa; Mazowieckie; Postal Code: 05-850

Contact Details: Purchase the Phoenix Pharma Polska Sp. z o.o. report to view the information.

Basic Information
Total Employees:
Purchase the Phoenix Pharma Polska Sp. z o.o. report to view the information.
Registered Capital:
Purchase the Phoenix Pharma Polska Sp. z o.o. report to view the information.
Financial Auditors:
Purchase the Phoenix Pharma Polska Sp. z o.o. report to view the information.
Incorporation Date:
August 10, 2001
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Proxy
Purchase this report to view the information.
Proxy
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Phoenix Pharma Polska Sp. z o.o. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency PLN. Absolute financial data is included in the purchased report.
Net sales revenue
67.11%
Total Operating Revenue
66.68%
Operating Profit
76.55%
EBITDA
146.49%
Net Profit/Loss for the Period
29.37%
Total Assets
29.12%
Total Equity
-34%
Operating Profit Margin
0.06%
Net Profit Margin
-0.39%
Return on Equity (ROE)
8.04%
Quick Ratio
-0.47%
Cash Ratio
-0.15%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?